Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells.

PloS one - 1 Jan 2013

Mauri Victor, Lotfi Parisa, Segatori Laura, Sardiello Marco

Abstract excerpt

A rapid and sensitive method to quantitatively assess N-acetylglucosaminidase (NAG) activity in cultured cells is highly desirable for both basic research and clinical studies. NAG activity is deficient in cells from patients with Mucopolysaccharidosis type IIIB (MPS IIIB) due to mutations in NAGLU, the gene that encodes NAG. Currently available techniques for measuring NAG activity in patient-derived cell lines...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylglucosaminidase
Share to Basic Helix-Loop-Helix Leucine Zipper Transcription Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biological Assay

Share to Fibroblasts

Share to Lysosomes

Share to Mucopolysaccharidosis III

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 23840811
DOI: 10.1371/journal.pone.0068060
PMCID: PMC3695942

Genes

NAGLU
TFEB

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells.PMID 23840811Read ↗

Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy.Semantic proximity Read ↗

Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.Semantic proximity Read ↗

Residual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB.Semantic proximity Read ↗

Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue Homogenates.Semantic proximity Read ↗

Processing of mutant N-acetyl-α-glucosaminidase in mucopolysaccharidosis type IIIB fibroblasts cultured at low temperature.Semantic proximity Read ↗

Expression and characterization of human recombinant and alpha-N-acetylglucosaminidase.Semantic proximity Read ↗

The molecular basis of Sanfilippo syndrome type B.Semantic proximity Read ↗

In situ assessment of beta-hexosaminidase activity.Semantic proximity Read ↗

A Bioluminogenic HDAC Activity Assay: Validation and ScreeningSemantic proximity Read ↗

Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.Semantic proximity Read ↗

The pharmacological chaperone N-n-butyl-deoxygalactonojirimycin enhances β-galactosidase processing and activity in fibroblasts of a patient with infantile GM1-gangliosidosis.Semantic proximity Read ↗

BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.